Richard Salvi Selected Research

Sodium Salicylate (Salicylate, Sodium)

1/2021	Functional Neuroanatomy of Salicylate- and Noise-Induced Tinnitus and Hyperacusis.
1/2020	Functional magnetic resonance imaging of enhanced central auditory gain and electrophysiological correlates in a behavioral model of hyperacusis.
1/2019	Aberrant thalamocortical coherence in an animal model of tinnitus.
1/2019	Testing the Central Gain Model: Loudness Growth Correlates with Central Auditory Gain Enhancement in a Rodent Model of Hyperacusis.
1/2017	Salicylate-induced hyperacusis in rats: Dose- and frequency-dependent effects.
9/2015	Potassium ion channel openers, Maxipost and Retigabine, protect against peripheral salicylate ototoxicity in rats.
1/2013	Salicylate-induced cochlear impairments, cortical hyperactivity and re-tuning, and tinnitus.
8/2010	Effects of sodium salicylate on spontaneous and evoked spike rate in the dorsal cochlear nucleus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard Salvi Research Topics

Disease

34	Hearing Loss (Hearing Impairment) 01/2022 - 05/2004
27	Tinnitus 02/2022 - 04/2004
19	Ototoxicity 01/2022 - 11/2004
16	Hyperacusis (Phonophobia) 10/2021 - 11/2012
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 11/2004
6	Sensorineural Hearing Loss 12/2020 - 01/2013
4	Noise-Induced Hearing Loss (Acoustic Trauma) 08/2021 - 12/2011
4	Neoplasms (Cancer) 01/2016 - 03/2002
3	Deafness (Deaf Mutism) 01/2022 - 10/2007
3	Wounds and Injuries (Trauma) 01/2019 - 12/2011
3	Bacterial Infections (Bacterial Infection) 11/2017 - 11/2004
2	Neuroinflammatory Diseases 01/2022 - 01/2016
2	Inflammation (Inflammations) 01/2022 - 01/2016
2	Pain (Aches) 01/2020 - 01/2016
2	Meniere Disease (Menieres Disease) 06/2015 - 05/2004
1	Unilateral Hearing Loss 07/2022
1	Seizures (Absence Seizure) 01/2022
1	Hypersensitivity (Allergy) 12/2021
1	Cataract (Cataracts) 08/2021
1	Vision Disorders (Hemeralopia) 08/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2021
1	Nerve Degeneration 01/2021
1	Demyelinating Diseases (Demyelinating Disease) 12/2020
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 10/2020
1	Hyperalgesia 01/2020
1	Hearing Disorders (Hearing Disorder) 01/2017

Drug/Important Bio-Agent (IBA)

19	SalicylatesIBA 10/2021 - 04/2004
15	Pharmaceutical PreparationsIBA 01/2022 - 03/2002
8	Sodium Salicylate (Salicylate, Sodium)IBA 01/2021 - 08/2010
5	AntioxidantsIBA 01/2022 - 01/2013
5	Biological ProductsIBA 10/2021 - 11/2008
5	Cisplatin (Platino)FDA LinkGeneric 12/2019 - 08/2008
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 11/2004
3	PlasticsIBA 07/2022 - 01/2014
3	Hormones (Hormone)IBA 01/2022 - 01/2017
3	CyclodextrinsIBA 01/2022 - 01/2021
3	CholesterolIBA 01/2022 - 10/2020
3	CorticosteroneIBA 01/2022 - 01/2017
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2021 - 01/2017
3	Superoxides (Superoxide)IBA 08/2021 - 11/2004
3	AminoglycosidesIBA 11/2017 - 11/2004
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 12/2011
3	Carboplatin (JM8)FDA LinkGeneric 01/2016 - 03/2002
2	Minocycline (Cyclops)FDA LinkGeneric 01/2022 - 11/2004
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2021 - 11/2004
2	Dihydrotachysterol (AT 10)IBA 01/2021 - 10/2011
2	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2020 - 12/2019
2	EnzymesIBA 12/2019 - 01/2017
2	Kanamycin FDA Link 11/2017 - 10/2011
2	Ethacrynic Acid (Etacrynic Acid)FDA Link 12/2016 - 10/2011
2	Furosemide (Lasix)FDA LinkGeneric 12/2016 - 11/2011
2	DiureticsIBA 12/2016 - 11/2011
2	CaspasesIBA 10/2015 - 11/2004
2	Potassium Channels (Potassium Channel)IBA 09/2015 - 10/2011
2	BMS204352IBA 09/2015 - 10/2011
2	Mefloquine (Lariam)FDA LinkGeneric 01/2013 - 07/2011
2	Gentamicins (Gentamicin)FDA LinkGeneric 11/2004 - 05/2004
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2022
1	Metabotropic Glutamate 5 ReceptorIBA 12/2021
1	Reactive Nitrogen SpeciesIBA 08/2021
1	MetalsIBA 08/2021
1	ParaquatIBA 08/2021
1	Sirtuin 3IBA 08/2021
1	LipidsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	2-Hydroxypropyl-beta-cyclodextrinIBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 12/2020
1	Adenosine A2B ReceptorIBA 12/2020
1	Chelating AgentsIBA 10/2020
1	CreatinineIBA 03/2020
1	AlbuminsIBA 03/2020
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Glutathione Transferase (Glutathione S-Transferase)IBA 12/2019
1	Mitochondrial DNA (mtDNA)IBA 10/2019
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2019
1	GlucocorticoidsIBA 01/2019
1	D-JNKI-1IBA 10/2018
1	Protein Kinases (Protein Kinase)IBA 10/2018
1	Carbaryl (Sevin)IBA 03/2017
1	NADP (NADPH)IBA 01/2017
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2017
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2017
1	DiquatIBA 01/2017
1	NucleotidesIBA 01/2017
1	ThioredoxinsIBA 01/2017
1	Cadherins (E-Cadherin)IBA 01/2017
1	Glucose-6-PhosphateIBA 01/2017
1	isocitric acid (isocitrate)IBA 01/2017
1	6-phosphogluconic acidIBA 01/2017

Therapy/Procedure

12	Therapeutics 02/2022 - 11/2004
2	Oral Administration 08/2021 - 12/2015
2	Electrodes (Electrode) 01/2019 - 11/2008
2	Castration 01/2008 - 11/2006
1	Transcranial Magnetic Stimulation 02/2022
1	Caloric Restriction 08/2021
1	Enzyme Therapy 12/2020
1	Analgesia 01/2020